- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GENTIAN DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 11.04. | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics: Notice of annual general meeting | 1 | Oslo Børs | ||
| 07.04. | GENTIAN DIAGNOSTICS ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
| 28.03. | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics strengthens commercial capabilities with key appointments | - | Oslo Børs | ||
| 21.03. | GENTIAN DIAGNOSTICS ASA: Correction: Gentian Diagnostics: Annual report 2024 | 2 | Oslo Børs | ||
| 21.03. | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics: Annual report 2024 | - | Oslo Børs | ||
| 19.03. | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics Receives Notice of Allowance for NT-proBNP Assay Patent in Japan | - | Oslo Børs | ||
| 12.03. | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics: Key information relating to the proposed cash dividend | 1 | Oslo Børs | ||
| 10.03. | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics and Beckman Coulter Partner to Launch Gentian GCAL® Calprotectin Immunoassay | 5 | Oslo Børs | ||
| 03.03. | GENTIAN DIAGNOSTICS ASA: Mandatory notification of trade | - | Oslo Børs | ||
| 03.03. | GENTIAN DIAGNOSTICS ASA: Notification of trade | 1 | Oslo Børs | ||
| 03.03. | GENTIAN DIAGNOSTICS ASA: Disclosure of shareholdings - Holta Invest AS | 1 | Oslo Børs | ||
| 03.03. | GENTIAN DIAGNOSTICS ASA: Disclosure of large shareholding in Gentian Diagnotics ASA | 1 | Oslo Børs | ||
| 05.02. | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics: Invitation to presentation of fourth quarter results | - | Oslo Børs | ||
| 16.12.24 | GENTIAN DIAGNOSTICS ASA: Mandatory notification of trade | - | Oslo Børs | ||
| 04.12.24 | GENTIAN DIAGNOSTICS ASA: Financial calendar | 1 | Oslo Børs | ||
| 26.11.24 | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics presents at the DNB Nordic Healthcare Conference | 2 | Oslo Børs | ||
| 31.10.24 | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics: Third quarter 2024 report | 1 | Oslo Børs | ||
| 24.10.24 | GENTIAN DIAGNOSTICS ASA: Gentian Diagnostics: Invitation to presentation of third quarter results | - | Oslo Børs |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRAUMANN | 103,18 | -100,00 % | Dividendenbekanntmachungen (16.04.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ANORA GROUP OYJ FI4000292438 - 0,22 EUR BBGI GLOBAL INFRASTRUCTURE SA LU0686550053 0,042 GBP EUR COPT DEFENSE PROPERTIES US22002T1088 0... ► Artikel lesen | |
| ALCON | 80,82 | -0,39 % | Alcon proposes CHF 0.28 dividend | ||
| TECAN GROUP | 151,40 | -1,88 % | CUTISS und Tecan automatisieren Herstellung von Hautgewebe | ||
| GALENICA | 89,53 | +0,53 % | «The Week»: Finanzwerte und Gold zeigen ihre Stärken: Galenica überzeugt weiterhin - Werfen ... | ||
| COLTENE | 63,90 | +0,95 % | Dominik Arnold, CEO Coltene, im Interview | von Bob Buchheit Moneycab.com: Herr Arnold, der Gruppenumsatz profitierte im letzten Geschäftsjahr besonders von Coltène/Whaledent in den USA. Gibt der Amerikaner viel für sein Gebiss aus? Dominik Arnold:... ► Artikel lesen | |
| OPTION CARE HEALTH | 28,000 | +0,72 % | Option Care Health, Inc.: Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2024 | BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate... ► Artikel lesen | |
| ADVANCED MEDICAL SOLUTIONS | 2,200 | +1,85 % | Adv Medical Solutns. - Rule 2.9 Announcement | ||
| ENVVENO MEDICAL | 2,020 | -5,61 % | enVVeno Medical Corporation: enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment | Moderated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Tuesday, April 22nd at 4:00 PM ET IRVINE, CA / ACCESS Newswire / April 16, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO)... ► Artikel lesen | |
| C-RAD | 2,585 | +0,78 % | C-Rad AB: C-RAD's Year-End Report January-December 2024 | Closing the year with recovered order intake and continued profitability
Fourth quarter 2024Order intake increased 13 percent to MSEK 167.5 (148.5). 13 percent growth also at constant exchange rates.Revenue... ► Artikel lesen | |
| IRADIMED | 45,000 | 0,00 % | Dividendenbekanntmachungen (24.02.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANCED ENERGY INDUSTRIES INC US0079731008 0,1 USD 0,0955 EUR ASX LIMITED ADR US00212E1038 0,697 USD 0,6662 EUR BANCA GENERALI... ► Artikel lesen | |
| CRYO-CELL INTERNATIONAL | 4,900 | +9,38 % | CRYO CELL INTERNATIONAL INC - 10-Q, Quarterly Report | ||
| INFUSYSTEM | 4,300 | -1,38 % | InfuSystem Reports Third Quarter 2024 Financial Results | ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient... ► Artikel lesen | |
| RAMSAY GENERALE DE SANTE | 9,440 | 0,00 % | RAMSAY SANTE: Ramsay Generale de Sante: preparatory documents availability for the 2024 General Meeting |
GENTIAN DIAGNOSTICS ASA gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,010 (+0,27 %) liegt der Kurs bei 3,680 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GENTIAN DIAGNOSTICS ASA finden Sie auf Wallstreet Online.
